Family Cancer Caregivers Receiving a Specific Supportive Care Intervention Pre- and Postloss
NCT ID: NCT03850132
Last Updated: 2019-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2014-07-27
2017-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Nurse-led Supportive Care on Caregiver Burden and Well-being
NCT05470543
Caregivers' Strengths-Skills: Managing Older Cancer Patients' Symptoms
NCT03532061
Intervention to Improve Supportive Care for Family Caregivers of Patients With Lung Cancer
NCT02531464
Compassion Meditation for Cancer Survivor-Caregiver Dyads
NCT03459781
Caregiver Stress and Bereavement
NCT05867706
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FAM-SOTC-PL
Grief responses, levels of vulnerability, measured using the Adult Attitude to Grief scale (AAG), a self-administered questionnaire
FAM-SOTC-PL
The adapted FAM-SOTC-PL intervention was delivered at the home of the participants and focuses on supporting the effective, cognitive, and behavioural domains of the bereaved family caregivers experience by targeting concerns/issues in these categories. The FAM-SOTC-PL comprises of the following five components:
1. Drawing forward narratives about the pre- and post-loss experience.
2. Asking therapeutic/interventive questions, emphasising on the most pressing concerns also assessing health issues.
3. Validating/acknowledging emotional responses.
4. Assessing the need for specific information and recommendations regarding bereavement.
5. The use of commendation/commending strengths, by focusing on and affirming the strengths of the family caregiver.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FAM-SOTC-PL
The adapted FAM-SOTC-PL intervention was delivered at the home of the participants and focuses on supporting the effective, cognitive, and behavioural domains of the bereaved family caregivers experience by targeting concerns/issues in these categories. The FAM-SOTC-PL comprises of the following five components:
1. Drawing forward narratives about the pre- and post-loss experience.
2. Asking therapeutic/interventive questions, emphasising on the most pressing concerns also assessing health issues.
3. Validating/acknowledging emotional responses.
4. Assessing the need for specific information and recommendations regarding bereavement.
5. The use of commendation/commending strengths, by focusing on and affirming the strengths of the family caregiver.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Iceland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UIceland-12018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.